AVAH

Business Context and Reporting Period

Company: Aveanna Healthcare Holdings, Inc. (AVAH)
Filing Type: Form 10-K (Annual Report)
Fiscal Year Ended: January 3, 2026 (53-week fiscal year)
Business Overview: Aveanna is a leading, diversified home care platform providing services to medically complex, high-cost patient populations. Operations are organized into three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The company operates in 38 states, primarily serving Medicaid and Medicare beneficiaries.

Key Financial Metrics

Note: Available liquidity includes $225.5 million under the Revolving Credit Facility and $110.0 million under the Securitization Facility as of January 3, 2026.

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenue increased 20.2% year-over-year, driven by a 22.4% increase in PDS revenue, 14.1% in HHH, and 6.6% in MS. PDS growth was fueled by volume increases (11.0%) and higher revenue rates (11.4%) due to Medicaid rate increases and the Thrive acquisition.
• Profitability Improvement: Operating income surged 83.5% to $256.5 million. This was primarily driven by a 54.2% increase in Field Contribution ($436.0 million), resulting from improved gross margins and better leverage of branch administrative expenses.
• Net Income Turnaround: The company reported a net income of $225.0 million compared to a net loss of $10.9 million in the prior year. This shift was significantly aided by an income tax benefit of $118.1 million (vs. expense of $16.0 million) due to the release of valuation allowances on deferred tax assets.
• Debt Restructuring: In September 2025, the company refinanced its credit facilities, replacing existing term loans and a second lien term loan with new 2025 Term Loans ($1.325 billion) and a Revolving Credit Facility ($250 million). This reduced the weighted average interest rate from 9.2% to 7.3%.
• Acquisitions: Completed the acquisition of Thrive Skilled Pediatric Care, LLC in June 2025 for approximately $75.7 million (cash and stock), adding 23 locations.

Guidance, Outlook, Risks, and Unusual Items

• Recent Developments: On March 12, 2026, the company announced an agreement to acquire Family First Holding, LLC for $175.5 million, expected to close in Q2 2026.
• Regulatory Risks:
  • Medicare Rate Cuts: CMS released a final rule for fiscal year 2026 reducing home health reimbursement rates by 1.3%.
  • Medicaid Changes: The "One Big Beautiful Bill Act" (OBBBA) enacted in 2025 includes provisions that may reduce Medicaid spending and tighten eligibility, potentially impacting future reimbursement rates indirectly.
  • Compliance: The company faces ongoing audits and investigations, including a DOJ Antitrust Division inquiry regarding nurse wages and hiring activities, and a DOJ investigation into a hospice subsidiary regarding improper claims and remuneration.
• Unusual Items:
  • Tax Benefit: A significant $118.1 million income tax benefit was recorded due to the release of valuation allowances, which is not a recurring operational driver.
  • Debt Extinguishment: A $5.9 million loss was recorded on debt extinguishment related to the September 2025 refinancing.
  • Derivative Losses: Valuation losses on interest rate derivatives increased to $29.7 million in 2025 compared to $15.2 million in 2024, impacting "Other (expense) income."
• Outlook: Management expects to continue gaining market share through organic growth and acquisitions. The company is focused on value-based care arrangements and leveraging its scale to optimize reimbursement rates and manage labor costs.

Key Facts for Investor Verification

• Debt Covenants: Verify compliance with the maintenance leverage covenant on the Revolving Credit Facility, which becomes effective if more than 40% of the commitment is utilized.
• Reimbursement Sensitivity: Assess the potential impact of the 1.3% Medicare rate cut and the OBBBA Medicaid provisions on the PDS and HHH segments, which rely heavily on government payers (approx. 81.5% of revenue).
• Acquisition Integration: Monitor the integration progress and synergy realization from the Thrive acquisition and the pending Family First Holding acquisition.
• Legal Contingencies: Track the status of the DOJ Antitrust investigation and the hospice subsidiary investigation for potential financial liabilities or operational restrictions.
• Interest Rate Exposure: Review the effectiveness of interest rate caps and swaps in mitigating the risk of rising SOFR rates on the $1.487 billion variable-rate debt portfolio.